Bottom line
IDEV vs HFXI: the short answer
IDEV (iShares Core MSCI International Developed Markets ETF) and HFXI (NYLI FTSE International Equity Currency Neutral ETF) share a meaningful slice of their top holdings — about 72% by weight.
But IDEV is far broader, holding 2,337 positions to 930 for HFXI, so beyond the top names it adds exposure HFXI doesn't have.
IDEV is cheaper at 0.04% vs 0.2% — a difference of $16 a year per $10,000 invested.
Over five years, HFXI returned +11.2% a year vs +5.0% for IDEV (reporting dates differ).
Updated Nov 19, 2026
IDEV vs HFXI side by side
| IDEV | HFXI | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | New York Life Investments |
| Category | International Stock | International Stock |
| Expense ratio | 0.04% | 0.2% |
| Annual cost per $10k | $4 | $20 |
| 10-yr cost on $10k (prospectus) | $51 | $255 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +4.5% | +30.1% |
| 5-yr return (annualized) | +5.0% | +11.2% |
| 10-yr return (annualized) | — | +9.5% |
| Best quarter | +16.9% | +15.0% |
| Worst quarter | −24.0% | −21.3% |
| Net assets (fund) | $31.6B | $2.0B |
| Number of holdings | 2,337 | 930 |
| Portfolio turnover | 3% | 14% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IDEV | HFXI | Difference |
|---|---|---|---|
| 2024 | +4.5% | +7.6% | −3.1% |
| 2023 | +17.3% | +19.5% | −2.2% |
| 2022 | −14.9% | −10.6% | −4.3% |
| 2021 | +12.7% | +13.9% | −1.2% |
| 2020 | +8.4% | +7.2% | +1.2% |
| 2019 | +23.4% | +22.9% | +0.5% |
| 2018 | −14.3% | −12.0% | −2.4% |
Source: Fund prospectus bar charts
Holdings overlap
16 of IDEV's top 25 holdings also appear in HFXI's top 25.
| Holding | IDEV | HFXI |
|---|---|---|
| ASML Holding N.V. | 2.19% | 2.43% |
| Hsbc Holdings Plc | 1.24% | 1.38% |
| Roche Holding AG | 1.05% | 1.22% |
| Novartis AG | 0.98% | 1.12% |
| Astrazeneca Plc | 0.88% | 0.97% |
| Shell Plc | 0.88% | 0.98% |
| Mitsubishi UFJ Financial Group, Inc. | 0.82% | 0.96% |
| Commonwealth Bank Of Australia | 0.72% | 0.81% |
| Banco Santander, S.A. | 0.70% | 0.78% |
| Sap Se | 0.65% | 0.72% |
| Allianz SE | 0.65% | 0.75% |
| Schneider Electric Se | 0.63% | 0.71% |
| Totalenergies Se | 0.59% | 0.67% |
| UBS Group AG | 0.57% | 0.64% |
| Rolls-royce Holdings Plc | 0.57% | 0.64% |
Source: SEC Form N-PORT
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
HFXI top 10
- Samsung Electronics Co Ltd — 3.70%
- Sk Hynix Inc — 2.61%
- Asml Holding Nv — 2.43%
- Hsbc Holdings Plc — 1.38%
- Roche Holding Ag — 1.22%
- Novartis Ag — 1.12%
- Shell Plc — 0.98%
- Nestle' Sa/ag — 0.98%
- Astrazeneca Plc — 0.97%
- Mitsubishi Ufj Financial Group Inc — 0.96%
FAQ
What is the difference between IDEV and HFXI?
Which is cheaper, IDEV or HFXI?
Should I own both IDEV and HFXI?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.